The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aadia Rana, M.D.
Alabama CTU
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico Aids Clinical Trials Unit Crs
San Juan, Puerto Rico
- Alabama Crs
Birmingham, Alabama, United States
- Ucla Care Center Crs
Los Angeles, California, United States
- University of Southern California Crs
Los Angeles, California, United States
- Ucsd Antiviral Research Center Crs
San Diego, California, United States
- Ucsf Hiv/aids Crs
San Francisco, California, United States
- Harbor-Ucla Crs
Torrance, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Univ. of Florida Jacksonville Nichd Crs
Jacksonville, Florida, United States
- the Ponce de Leon Center Crs
Atlanta, Georgia, United States
- Northwestern University Crs
Chicago, Illinois, United States
- Rush University Crs
Chicago, Illinois, United States
- Johns Hopkins University Crs
Baltimore, Maryland, United States
- Brigham and Women'S Hospital Therapeutics Clinical Research Site (bwh Tcrs) Crs
Boston, Massachusetts, United States
- Massachusetts General Hospital Crs (mgh Crs)
Boston, Massachusetts, United States
- Washington University Therapeutics (wt) Crs
St Louis, Missouri, United States
- New Jersey Medical School Clinical Research Center Crs
Newark, New Jersey, United States
- Columbia P&s Crs
New York, New York, United States
- Weill Cornell Chelsea Crs
New York, New York, United States
- Weill Cornell Uptown Crs
New York, New York, United States
- Suny Stony Brook Nichd Crs
Stony Brook, New York, United States
- Jacobi Med. Ctr. Bronx Nichd Crs
The Bronx, New York, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
- Greensboro Crs
Greensboro, North Carolina, United States
- Cincinnati Clinical Research Site
Cincinnati, Ohio, United States
- Case Clinical Research Site
Cleveland, Ohio, United States
- Ohio State University Crs
Columbus, Ohio, United States
- Penn Therapeutics, Crs
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Crs
Pittsburgh, Pennsylvania, United States
- the Miriam Hospital Clinical Research Site (tmh Crs) Crs
Providence, Rhode Island, United States
- Vanderbilt Therapeutics (vt) Crs
Nashville, Tennessee, United States
- Houston Aids Research Team Crs
Houston, Texas, United States
- University of Washington Aids Crs
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Mar 2019
- Primary completion
- 12 Feb 2024
- Completion
- 30 Aug 2026
- Last update posted
- 24 Jun 2026
- Registered enrollment
- 456
- Registry id
- NCT03635788
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.